United Therapeutics reported $175.6M in Operating Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Amarin AMRN:US 122.94M 5.42M
Ardelyx ARDX:US $ 28.28M 8.03M
Baxter International BAX:US $ 3544M 376M
Bayer BAYN:GR 10.43B 1.33B
Biocryst Pharmaceuticals BCRX:US $ 99.88M 56.38M
Biogen BIIB:US $ 1921.1M 225.6M
Biomarin Pharmaceutical BMRN:US $ 382.03M 133.66M
Emergent Biosolutions EBS:US $ 301.1M 144.7M
Esperion Therapeutics ESPR:US $ 61.82M 9.2M
Gilead Sciences GILD:US $ 6393M 89M
GlaxoSmithKline GSK:LN 6.98B 1.65B
Halozyme Therapeutics HALO:US $ 41.61M 3.86M
Insmed INSM:US $ 142.94M 12.26M
Intercept Pharmaceuticals ICPT:US $ 98.85M 14.42M
Intra Cellular Therapies ITCI:US $ 107.66M 4.02M
Johnson & Johnson JNJ:US $ 17.56B 2.4B
Lexicon Pharmaceuticals LXRX:US 23.42M 1.93M
Moderna Inc MRNA:US 1.84B 38M
Pfizer PFE:US $ 15788M 3271M
Ptc Therapeutics PTCT:US $ 235.26M 14.7M
Regeneron Pharmaceuticals REGN:US $ 1706.6M 605.4M
Sangamo Biosciences SGMO:US $ 73.49M 5.61M
Sarepta Therapeutics SRPT:US $ 297.71M 9.56M
Seattle Genetics SGEN:US $ 559.51M 42.41M
Teva Pharmaceutical TEVA:IT 4.37B 352M
United Therapeutics UTHR:US $ 175.6M 69.8M
Vertex Pharmaceuticals VRTX:US $ 1056.6M 138.24M